Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neogen ChemicalsNSE:NEOGEN -2.64%87 EV-to-EBIT is 57.82 as of Sep. 16, 2026, which is 40% above its 10-year median of 41.25. GuruFocus rates NSE:NEOGEN with a GF Score™ of 87/100 and a GF Value™ of ₹2,115.33 (Fairly Valued). The stock has 12 warning signs investors should review. Among 1,290 Chemicals companies, Neogen Chemicals ranks worse than 86.82% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Neogen Chemicals's Enterprise Value for the quarter that ended in Jun. 2026 was ₹0 Mil.
Neogen Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,333 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen Chemicals EV-to-EBIT Related Terms
Neogen Chemicals EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Neogen Chemicals's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEOGEN vs LIN, SHW, ECL: EV-to-EBIT Comparison
For the Specialty Chemicals subindustry, Neogen Chemicals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen Chemicals EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Neogen Chemicals's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Neogen Chemicals's EV-to-EBIT falls into.
Neogen Chemicals's current Enterprise Value is ₹77,081 Mil.
Neogen Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,333 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen Chemicals (NSE:NEOGEN) has a EV-to-EBIT of 57.82 as of Sep. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Neogen Chemicals and its competitors. This is 40% above median its historical median of 41.25. Over the past decade, Neogen Chemicals' EV-to-EBIT has ranged from 14.12 to 70.62. According to the industry distribution chart, Neogen Chemicals ranks #1120 out of 1290 companies in the Chemicals industry, placing it in the top 86.8%.
Is Neogen Chemicals' EV-to-EBIT too high?
Neogen Chemicals' current EV-to-EBIT of 57.82 is 40% above median its 10-year median of 41.25. Over the past 10 years, this metric has ranged from a low of 14.12 to a high of 70.62. The Chemicals industry median EV-to-EBIT is 16.33. Neogen Chemicals' value of 57.82 is 254.1% above this industry median. Based on the distribution chart, Neogen Chemicals ranks #1120 out of 1290 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Neogen Chemicals has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neogen Chemicals' EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Neogen Chemicals ranks #1120 out of 1290 companies for EV-to-EBIT. This places Neogen Chemicals in the lower half of its industry. The industry median EV-to-EBIT is 16.33. Neogen Chemicals' value of 57.82 is 254.1% above this benchmark. Historically, Neogen Chemicals' own EV-to-EBIT has ranged from 14.12 to 70.62 over the past decade. While the company's 10-year median is 41.25 vs. the industry median of 16.33, Neogen Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.33, based on 1,290 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neogen Chemicals's current EV-to-EBIT of 57.82 is 254.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Neogen Chemicals and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neogen Chemicals's current EV-to-EBIT is 57.82, which is 40% above median its own 10-year median of 41.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Neogen Chemicals (NSE:NEOGEN) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,115.33, compared to a current price of ₹2,310.30 — trading 9.2% above its estimated fair value. The current EV-to-EBIT is 57.82, which is 40% above median its 10-year median of 41.25 and 254.1% above the Chemicals industry median of 16.33. Neogen Chemicals' overall GF Score™ is 87/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Neogen Chemicals (NSE:NEOGEN), the current EV-to-EBIT is 57.82 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neogen Chemicals (NSE:NEOGEN) Overvalued in 2026?
Based on GuruFocus' analysis, Neogen Chemicals stock appears to be overvalued.
The current stock price of ₹2,310.30 is trading 9.2% above its estimated GF Value™ of ₹2,115.33.
GuruFocus considers Neogen Chemicals to be Fairly Valued.
Key valuation signals for NSE:NEOGEN:
EV-to-EBIT: 57.82 (40% above median its 10-year median of 41.25)
GF Value™: ₹2,115.33 vs. price of ₹2,310.30 (9.2% above fair value)
Industry Position: 254.1% above the Chemicals median (#1120 of 1290)
No single metric tells the full story. See the NSE:NEOGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neogen Chemicals Ltd is engaged in the manufacturing of specialty chemicals that are used in the Pharmaceutical, Engineering and Agro-Chemical industries. The company manufactures bromine-based and lithium-based specialty chemicals. Its products include Organobromine compounds, Chloro compounds, Inorganic bromine compounds, Lithium Salts and others. Geographically, It generates the majority of the revenue from India and also exports to other countries.
87GF Score
Get the complete analysis for NSE:NEOGEN
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEOGEN has been successfully added to your 
